This Study Aim is to Compare the Effect of Oral Methyl Prednisolone on

Status Recruiting

Clinical Trial Summary

The Aim of This Work is to Compare the Effect of Oral Methyl Prednisolone on Different Radiological Patterns of Hypersensitivity Pneumonitis and to Evaluate the Patient's Clinical and Functional Status After Taking the Required Dose of Methyl Prednisolone. Not All Hypersensitivity Pneumonitis Patients get the Same Therapeutic Effect after taking Corticosteroid so by Comparing the Effect of Methyl Prednisolone on Patients With Different Radiological Pattern we Will be Able to Select the Patient Who Really Need to Take Corticosteroid and Who Don't so we Will Protect the Patient Who Doesn't Need to Take Oral Corticosteroids From Its Numerous Side Effects All Patients Will Undergo the Following Assessment Before and After Taking 0.5 mg/kg/Day of Methyl Prednisolone for 8 Weeks : High Resolution CT (HRCT) of Chest , Chest X-ray , Spirometry, 6 Minute Walk Test to Evaluate the Patient's Functional Status and Oximetry to Measure Percentage of Oxygen in Blood

Clinical Trial Description

hypersensitivity Pneumonitis patients will be divided in two groups : non- fibrotic hypersensitivity Pneumonitis patients ( nfHP) and fibrotic hypersensitivity Pneumonitis patients ( fHP), based on HRCT findings.

All patients will undergo the following assessment at the beginning of the study: High resolution CT (HRCT) of chest , Spirometry to assess forced expiratory volume in 1 second (FEV1), Forced vital capacity (FVC) and FEV1 to FVC ratio , 6minute walk test , Oximetry to measure percentage of oxygen in blood. Then all patients took methyl prednisolone 0.5mg/kg /day orally for 8 weeks .

During the treatment period Pulmonary spirometry will be done every 2 weeks and 6 minute walk test will be done every 4 weeks as follow up At the end of the treatment period all these assessments will be repeated to compared the patients functional and clinical statues before and after taking methylprednisolone. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04402177
Study type	Interventional
Source	Al-Azhar University
Contact	Fatma Ahmed T Shalaby
Phone	01004839333
Email	Fatmatony242@gmail.com
Status	Recruiting
Phase	Phase 4
Start date	July 1, 2020
Completion date	July 1, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05549635` - Database and Biobank of Patients With Hypersensitivity Pneumonitis
Completed	`NCT02523833` - Small Airway Involvement in Patients With Chronic Hypersensitivity Pneumonitis	N/A
Completed	`NCT03873649` - Immune Response in Hypersensitivity Pneumonitis
Recruiting	`NCT05626387` - An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis	Phase 4
Recruiting	`NCT05365802` - FAPI PET for Lung Fibrosis	Early Phase 1
Completed	`NCT01487850` - Wind Instruments' Fungal Contamination	N/A
Withdrawn	`NCT04677426` - 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study	Phase 2
Recruiting	`NCT04961944` - HypErsensitiVity PneumonITis: DiseAse Progression Characterization
Not yet recruiting	`NCT03800017` - Skeletal Muscle Function in Interstitial Lung Disease	N/A
Not yet recruiting	`NCT04561479` - Pulmonary Rehabilitation in Patients With Chronic Fibrotic Hypersensitivity Pneumonitis	N/A
Completed	`NCT04273867` - Assessing Health Related Quality of Life in Hypersensitivity Pneumonitis
Completed	`NCT05723796` - Study of Nasal Mucosa Histopathological Changes in Chronic Hypersensitivity Pneumonitis	N/A
Recruiting	`NCT04844359` - A Prognostic Transcriptomic Signature for Chronic Hypersensitivity Pneumonitis
Enrolling by invitation	`NCT05727852` - Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
Not yet recruiting	`NCT05988437` - Contribution of the Indoor Environment Medical Advisor in the Management of Fibrosing Hypersensitivity Pneumonitis
Completed	`NCT04675619` - Evaluation of the Efficacy of Pirfenidone in Progressive Chronic Hypersensitivity Pneumonitis	Phase 2
Recruiting	`NCT05392881` - Interstitial Lung Disease Research Unit Biobank
Enrolling by invitation	`NCT04896138` - University of Virginia Natural History Study
Completed	`NCT05458635` - Predictors of Pulmonary Hypertension in Patients With Hypersensitivity Pneumonitis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

This Study Aim is to Compare the Effect of Oral Methyl Prednisolone on Different Radiological Patterns of Hypersensitivity Pneumonitis as it Was Found That Not All Patients Get Satisfying Therapeutic Effect After Taking Corticosteroids.

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms